ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2020

SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients.

André J ScheenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.